Literature DB >> 23478311

Prion protein regulates iron transport by functioning as a ferrireductase.

Ajay Singh1, Swati Haldar, Katharine Horback, Cynthia Tom, Lan Zhou, Howard Meyerson, Neena Singh.   

Abstract

Prion protein (PrPC) is implicated in the pathogenesis of prion disorders, but its normal function is unclear. We demonstrate that PrPC is a ferrireductase (FR), and its absence causes systemic iron deficiency in PrP knock-out mice (PrP-/-). When exposed to non-transferrin-bound (NTB) radioactive-iron (59FeCl3) by gastric-gavage, PrP-/- mice absorb significantly more 59Fe from the intestinal lumen relative to controls, indicating appropriate systemic response to the iron deficiency. Chronic exposure to excess dietary iron corrects this deficiency, but unlike wild-type (PrP+/+) controls that remain iron over-loaded, PrP-/- mice revert back to the iron deficient phenotype after 5 months of chase on normal diet. Bone marrow (BM) preparations of PrP-/- mice on normal diet show relatively less stainable iron, and this phenotype is only partially corrected by intraperitoneal administration of excess iron-dextran. Cultured PrP-/- BM-macrophages incorporate significantly less NTB-59Fe in the absence or presence of excess extracellular iron, indicating reduced uptake and/or storage of available iron in the absence of PrPC. When expressed in neuroblastoma cells, PrPC exhibits NAD(P)H-dependent cell-surface and intracellular FR activity that requires the copper-binding octa-peptide-repeat region and linkage to the plasma membrane for optimal function. Incorporation of NTB-59Fe by neuroblastoma cells correlates with FR activity of PrPC, implicating PrPC in cellular iron uptake and metabolism. These observations explain the correlation between PrPC expression and cellular iron levels, and the cause of iron imbalance in sporadic-Creutzfeldt-Jakob-disease brains where PrPC accumulates as insoluble aggregates.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23478311      PMCID: PMC5450724          DOI: 10.3233/JAD-130218

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  48 in total

1.  Altered circadian activity rhythms and sleep in mice devoid of prion protein.

Authors:  I Tobler; S E Gaus; T Deboer; P Achermann; M Fischer; T Rülicke; M Moser; B Oesch; P A McBride; J C Manson
Journal:  Nature       Date:  1996-04-18       Impact factor: 49.962

Review 2.  Prion protein genes and prion diseases: studies in transgenic mice.

Authors:  G C Telling
Journal:  Neuropathol Appl Neurobiol       Date:  2000-06       Impact factor: 8.090

Review 3.  Iron imports. III. Transfer of iron from the mucosa into circulation.

Authors:  Marianne Wessling-Resnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-01       Impact factor: 4.052

4.  The cellular prion protein modulates phagocytosis and inflammatory response.

Authors:  Cecília J G de Almeida; Luciana B Chiarini; Juliane Pereira da Silva; Patrícia M R E Silva; Marco Aurélio Martins; Rafael Linden
Journal:  J Leukoc Biol       Date:  2004-11-11       Impact factor: 4.962

5.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

6.  Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.

Authors:  Subhabrata Basu; Maradumane L Mohan; Xiu Luo; Bishwajit Kundu; Qingzhong Kong; Neena Singh
Journal:  Mol Biol Cell       Date:  2007-06-13       Impact factor: 4.138

Review 7.  Systemic iron status.

Authors:  John Beard; Okhee Han
Journal:  Biochim Biophys Acta       Date:  2008-09-30

Review 8.  The prion's elusive reason for being.

Authors:  Adriano Aguzzi; Frank Baumann; Juliane Bremer
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

Review 9.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

10.  Prion protein (PrP) knock-out mice show altered iron metabolism: a functional role for PrP in iron uptake and transport.

Authors:  Ajay Singh; Qingzhong Kong; Xiu Luo; Robert B Petersen; Howard Meyerson; Neena Singh
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

View more
  36 in total

1.  Prion protein functions as a ferrireductase partner for ZIP14 and DMT1.

Authors:  Ajai K Tripathi; Swati Haldar; Juan Qian; Amber Beserra; Srinivas Suda; Ajay Singh; Ulrich Hopfer; Shu G Chen; Michael D Garrick; Jerrold R Turner; Mitchell D Knutson; Neena Singh
Journal:  Free Radic Biol Med       Date:  2015-04-08       Impact factor: 7.376

2.  Cellular prion protein activates Caspase 3 for apoptotic defense mechanism in astrocytes.

Authors:  Caroline M S Marques; Tatiana Pedron; Bruno L Batista; Giselle Cerchiaro
Journal:  Mol Cell Biochem       Date:  2021-02-05       Impact factor: 3.396

3.  Local synthesis of hepcidin in the anterior segment of the eye: A novel observation with physiological and pathological implications.

Authors:  Ajay Ashok; Suman Chaudhary; Dallas McDonald; Alexander Kritikos; Disha Bhargava; Neena Singh
Journal:  Exp Eye Res       Date:  2019-12-04       Impact factor: 3.467

4.  Iron and restless legs syndrome: treatment, genetics and pathophysiology.

Authors:  James R Connor; Stephanie M Patton; Konrad Oexle; Richard P Allen
Journal:  Sleep Med       Date:  2016-11-10       Impact factor: 3.492

5.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 6.  Prions and prion diseases: Insights from the eye.

Authors:  Neena Singh; Suman Chaudhary; Ajay Ashok; Ewald Lindner
Journal:  Exp Eye Res       Date:  2020-08-25       Impact factor: 3.467

Review 7.  The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin.

Authors:  Douglas G Peters; James R Connor; Mark D Meadowcroft
Journal:  Neurobiol Dis       Date:  2015-08-22       Impact factor: 5.996

Review 8.  Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis.

Authors:  Sanghamitra Bandyopadhyay; Jack T Rogers
Journal:  Biochem Pharmacol       Date:  2014-02-07       Impact factor: 5.858

Review 9.  Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Matthew K McElwee; Katharine Horback; Amber Beserra
Journal:  Antioxid Redox Signal       Date:  2014-02-27       Impact factor: 8.401

Review 10.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.